checkAd
    Perspective Therapeutics Aktie
    1,2900
     
    EUR
    +4,88 %
    +0,0600 EUR
    Letzter Kurs 31.05.24 Tradegate
    1,2500
     
    EUR
    1.601 STK
    Geldkurs 31.05.24
    1,3200
     
    EUR
    1.512 STK
    Briefkurs 31.05.24
    ISIN: US46489V1044 · WKN: A0MQNM · SYM: AAJ · USA

    Neueste Nachrichten

    Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
    24.05.24 · globenewswire · Perspective Therapeutics
    Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024
    20.05.24 · globenewswire · Perspective Therapeutics
    Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
    15.05.24 · globenewswire · Perspective Therapeutics
    Perspective Therapeutics to Participate at Upcoming May Investor Conferences
    03.05.24 · globenewswire · Perspective Therapeutics
    Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results
    02.05.24 · globenewswire · Perspective Therapeutics
    Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETs
    30.04.24 · globenewswire · Perspective Therapeutics
    Perspective Therapeutics to Participate at Upcoming April Investor Conferences
    08.04.24 · globenewswire · Perspective Therapeutics
    Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results
    28.03.24 · globenewswire · Perspective Therapeutics
    Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanoma
    18.03.24 · globenewswire · Perspective Therapeutics
    Perspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particle Radiotherapy for Cancer on March 18, 2024
    11.03.24 · globenewswire · Perspective Therapeutics
    Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility
    05.03.24 · globenewswire · Perspective Therapeutics
    Perspective Therapeutics Announces $87.4 Million Private Placement
    04.03.24 · globenewswire · Perspective Therapeutics